COPENHAGEN (Reuters) - Hedge fund Marshall Wace is betting on Danske Bank (DANSKE.CO) shares falling after taking a short position in the Danish lender of 0.5% of issued shares...
Keep Reading →
January 3 - Hedge Funds, Insider Trading
(Bloomberg) -- It has been yet another year to forget in the world of hedge funds.
Keep Reading →
December 27 - Hedge Funds, Insider Trading
Hedge fund titan David Tepper said Thursday the Federal Reserve is sending the market a message, and it’s not a good one.
Keep Reading →
December 20 - Hedge Funds, Insider Trading
(Reuters) - Activist investor John Paulson’s hedge fund on Thursday said it would urge Detour Gold Corp (DGC.TO) to call a special shareholder meeting to replace a majority ...
Keep Reading →
July 19 - Hedge Funds, Insider Trading
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...
Keep Reading →
February 28 - Hedge Funds
(Reuters) - Och-Ziff Capital Management on Tuesday named Robert Shafir as its new chief executive officer, succeeding Dan Och after a battle over who will run the hedge fund firm...
Keep Reading →
January 30 - Hedge Funds, Insider Trading
Elliott Management Corp., the hedge fund founded by billionaire Paul Singer, has built a stake in Sky Plc as shareholders prepare to vote on 21st Century Fox Inc.’s 11.7-billion...
Keep Reading →
January 29 - Hedge Funds, Insider Trading
Shares of Nike (NYSE:NKE) rose over 3% Friday morning following an upgrade by Wedbush to Outperform (from Neutral) with a new price target of $74.00 (from $57.00).
Keep Reading →
January 19 - Market Movers, News
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d...
Keep Reading →
September 11 - Hedge Funds
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...
Keep Reading →
August 8 - Hedge Funds
You can access the original SEC filing by clicking here.
Keep Reading →
July 10 - Hedge Funds
“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.
Keep Reading →
April 3 - Commodities, Gold, Market Movers, News, Tech
In order to ensure an extension of Ampyra’s protection to 2026, Acorda Therapeutics Inc (NASDAQ:ACOR) must fight off competition from competitors such as Roxane, Teva Pharmaceutical...
Keep Reading →
February 16 - News, Stock Analysis
Acorda Therapeutics Inc (NASDAQ:ACOR) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE:LLY) severe competition...
Keep Reading →
January 24 - News, Stock Analysis
To find a winner in the biotech space this week, all you’d need to do is throw a dart at a basket of micro-caps.
Keep Reading →
November 22 - Market Movers, News, Stock Analysis
The markets continue to trade down in anticipation of the upcoming OPEC meeting.
Keep Reading →
September 26 - Market Movers, News
Acorda Therapeutics Inc (NASDAQ:ACOR) is a $1.11 billion biotechnology company that develops and commercializes novel therapies for neurological disorders.
Keep Reading →
August 31 - News, Stock Analysis
We just got a couple of updates in the Parkinson’s space, and both have the potential to serve up some volatility in the market capitalisations of the companies in question.
Keep Reading →
August 5 - News, Stock Analysis
While many hedge funds are still preparing their third quarter filings with the SEC, providing the main ingredients for our delectable small-cap investment strategy, some managers...
Keep Reading →
November 2 - Commodities, Hedge Funds, News
Those who seek to profit from shorting strategies should keep a close eye on Kyle Bass’ war against the pharmaceutical industry.
Keep Reading →
September 17 - Hedge Funds, Macroeconomic Predictions, News
The shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are trading 13.16% higher today after the dismissal of a patent challenge against the company.
Keep Reading →
August 25 - Hedge Funds, Market Movers, News
Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment vehicles of a forgotten age.
Keep Reading →
September 17 - News
To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age.
Keep Reading →
September 11 - News
If you were to ask many of your fellow readers, hedge funds are seen as overrated, old investment vehicles of a period lost to current times.
Keep Reading →
August 30 - News
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Keep Reading →
August 22 - News
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Keep Reading →
August 6 - News
Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds' portfolio at the end of March.
Keep Reading →
June 12 - News
Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds' portfolio at the end of March.
Keep Reading →
June 3 - News
Small biotech companies have great investment potential if you can identify them properly.
Keep Reading →
April 24 - News
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.
Keep Reading →
April 20 - News
At the moment, there are dozens of methods market participants can use to monitor publicly traded companies. Some of the best are hedge fund and insider trading sentiment.
Keep Reading →
April 19 - News
At the moment, there are dozens of metrics shareholders can use to watch publicly traded companies. A couple of the most useful are hedge fund and insider trading activity.
Keep Reading →
April 19 - News
Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc.
Keep Reading →
April 15 - News
Roberto Mignone’s Bridger Management keeps their returns extremely secret. They do extensive analysis and follow a long/short strategy.
Keep Reading →
December 18 - Hedge Funds
Hedge Fund Resource Center 
